Ideal Power IPWR Detailed Report Ideal Power Inc posts 336 percent EPS beat on strong revenue AMLX Amylyx Pharmaceuticals Inc reports narrower Q4 2025 loss than estimates shares climb 355 percent on positive investor sentiment XWIN XMAX Inc reports 726 percent year over year Q4 2025 revenue growth slips 028 percent in trading